Source-backed guidance comparing botulinum toxin products for medical tourists, covering formulation differences, unit conversions, and evidence-based decision factors.
Last reviewed: 2026-05-06
11 min read
Ready to explore your options in Istanbul?
Connect with our coordination team for a personalised treatment plan, verified provider matching, and travel logistics support.
Content is educational and planning-oriented. It does not replace diagnosis, treatment, or personalized medical advice from a licensed healthcare professional. Outcomes vary by individual case.
Botox and Dysport are both botulinum toxin type A products but have different unit conversion ratios (2.5:1 to 3:1 Dysport to Botox) that your provider must calculate.
Dysport's greater diffusion may benefit larger treatment areas, while Botox's more localized spread can be preferable for precision work.
Onset and duration are similar (2-5 day onset, 3-4 month duration), though individual responses may vary based on metabolism and muscle characteristics.
Provider selection matters more than product choice—verify credentials, facility accreditation, and product authenticity before treatment.
Educational information only
This content is general education and does not replace evaluation by a licensed clinician. If you have symptoms, complications, or urgent concerns, seek in-person medical care.
Understanding Botox and Dysport
Botox and Dysport are both FDA-approved forms of botulinum toxin type A used for cosmetic and therapeutic applications. While they share the same fundamental mechanism—blocking nerve signals to muscles—they differ in formulation, potency, and approved uses. Understanding these differences helps you have more informed discussions with your provider about which option may be appropriate for your treatment goals.
For a broader overview of botulinum toxin treatments and how they fit into facial rejuvenation options, explore our Botox and Injectables Hub.
How Botulinum Toxin Type A Works
Both products work by inhibiting the release of acetylcholine, a neurotransmitter that signals muscles to contract. Specifically, they target SNAP-25, a protein essential for nerve signal transmission [S1]. This temporary interruption reduces muscle activity, softening the appearance of dynamic wrinkles and managing certain muscle-related conditions.
The molecular structure differs between the two products. Botox contains a 900 kDa molecular complex with human serum albumin, while Dysport uses a 500-900 kDa complex that includes human serum albumin and lactose as a stabilizing agent [S2]. These formulation differences contribute to variations in how each product spreads in tissue after injection.
Not Interchangeable at Equal Units
Botox and Dysport are not equivalent on a unit-for-unit basis. Using incorrect conversion ratios can result in over- or under-treatment. Always allow your provider to determine dosing based on their clinical experience with each product.
Key Differences Between the Two Products
Understanding the practical differences between Botox and Dysport helps you set realistic expectations and have meaningful conversations with potential providers. The most significant distinctions involve unit conversion, diffusion characteristics, and FDA approval status.
Unit Conversion: Why 1:1 Is Not Accurate
One of the most critical considerations when comparing these products is that their dosing is not equivalent. Clinical evidence supports a Dysport to Botox conversion ratio of 2.5:1 to 3:1 [S1]. This means approximately 2.5 to 3 units of Dysport are needed to achieve effects similar to 1 unit of Botox.
For example, when using a 3:1 ratio for cosmetic applications, 20 units of Botox would equate to approximately 60 units of Dysport [S1]. This difference is not merely academic—incorrect conversion can lead to excessive weakness, incomplete results, or shortened duration of effect. Pricing structures typically reflect these unit differences, so comparing "per-unit" costs without accounting for conversion ratios may be misleading.
Diffusion and Spread Characteristics
Dysport demonstrates greater diffusion into surrounding tissue following injection compared to Botox [S2]. This characteristic can be advantageous when treating larger areas, such as the forehead or platysmal bands in the neck, because the product spreads more widely from the injection site. For broader treatment zones, fewer injection points may be needed with Dysport.
However, greater diffusion carries potential trade-offs. The increased spread may raise the risk of affecting adjacent muscles unintentionally, which could lead to complications like ptosis (drooping eyelid) if treatment is near the eyes. Botox's more localized diffusion may be preferable for precision work in delicate areas where controlled, limited spread is desired.
The optimal product choice often depends on the specific treatment area and your provider's experience. Some practitioners prefer one product for certain applications and the other for different areas.
Onset, Duration, and Switching Products
Both Botox and Dysport typically show initial effects within 2-5 days of treatment, with full results visible within 7-14 days [S3][S4]. The duration of effect is generally comparable, ranging from 3-4 months for most patients, though individual responses vary based on factors such as metabolism, muscle strength, injection technique, and treatment area.
You can switch between products in subsequent treatments if desired. However, providers generally recommend allowing the effects of the current treatment to fully dissipate before starting a different product—typically waiting 3-4 months between treatments. When switching, your provider will recalculate the appropriate dose using the conversion ratio. Some patients report subtle differences in how each product "feels" or how quickly onset occurs, though clinical studies suggest comparable efficacy when properly dosed.
FDA Approval Status and What It Means
Botox has broader FDA approval with over 11 indications, including crow's feet, chronic migraine, hyperhidrosis (excessive sweating), and urinary incontinence [S2]. Dysport is FDA-approved for cervical dystonia (neck muscle spasms), glabellar lines (frown lines), and spasticity in both adults and children aged 2 years and older [S3].
Both products share approval for glabellar lines and cervical dystonia, meaning clinical evidence supports their safety and efficacy for these indications. For off-label uses—applications not specifically approved by the FDA—provider experience and clinical judgment become especially important factors in treatment decisions.
Treatment Areas and Product Selection
The choice between Botox and Dysport often depends on which area you wish to treat. Understanding how each product performs in different regions helps you discuss options knowledgeably with potential providers.
For detailed information about treatment procedures and what to expect during your visit, review our Botox Treatment Overview.
Upper Face Applications
For the forehead and glabellar region (between the eyebrows), both products produce comparable results when properly dosed. The glabellar lines indication is approved for both products, providing solid clinical evidence for this application [S2][S3]. Some providers report Dysport's diffusion benefits broader forehead treatments, while others prefer Botox for precise eyebrow shaping where spread control matters.
Crow's feet (lateral canthal lines) are FDA-approved for Botox specifically [S3]. If this is your primary concern, you may wish to discuss whether Dysport could be used off-label or whether Botox's specific approval for this area is relevant to your decision.
Lower Face and Neck
The masseter muscle (jawline) and platysmal bands (neck bands) are areas where Dysport's diffusion characteristics may offer advantages. The wider spread can effectively address these larger muscle groups with fewer injection points. However, precision matters too—over-diffusion in the lower face could affect your smile or chewing function.
Lower Face Considerations
Treatment of lower face areas requires careful technique due to the risk of affecting muscles involved in expression, eating, or speaking. Verify your provider has specific experience with these delicate areas.
Safety and Risk Management
Botulinum toxin injections carry risks that vary based on individual factors, treatment area, and provider technique. Understanding the safety profile helps you recognize normal reactions and warning signs.
Common Side Effects
Temporary side effects that resolve without intervention are relatively common. These may include mild bruising at injection sites, temporary headache (particularly after forehead treatment), and slight asymmetry during the onset period as the product takes effect [S1][S2]. These effects typically appear within the first week and resolve within several weeks.
Mild ptosis (eyelid drooping) can occur when treating upper face areas, particularly if the product spreads to muscles controlling eyelid position. This effect is usually temporary but may last several weeks in some cases.
Contraindications and Pre-Treatment Disclosure
Certain conditions may make botulinum toxin treatment inappropriate or require special precautions. Neuromuscular conditions such as myasthenia gravis or Lambert-Eaton syndrome may contraindicate treatment due to effects on muscle function [S3][S4]. Pregnancy and breastfeeding are contraindications for both products.
Medication interactions warrant disclosure, particularly aminoglycoside antibiotics and muscle relaxants, which may potentiate the effects of botulinum toxin [S3]. Your complete medication list, including supplements, should be reviewed during consultation.
Essential Disclosures
Before treatment, disclose: neuromuscular conditions, current medications (especially antibiotics and muscle relaxants), previous botulinum toxin treatments, allergies, and pregnancy status.
When to Seek Medical Attention
While serious adverse events are rare, certain symptoms warrant prompt medical evaluation. Signs of allergic reaction include difficulty breathing, hives, or swelling of the face, lips, tongue, or throat. Unusual muscle weakness patterns, vision disturbances, or swallowing difficulties should be evaluated promptly [S3][S4].
If you experience any concerning symptoms after returning home from treatment abroad, contact a local healthcare provider and inform them of your recent procedure. Keeping documentation of your treatment—including product name, dosage, and injection sites—supports appropriate follow-up care.
Practical Considerations for Your Decision
Selecting a provider and preparing for treatment involves more than choosing between products. The following factors significantly influence treatment safety and outcomes.
Questions to Ask Your Provider
During consultation, ask about the provider's specific experience with both products. How long have they used each one? For which treatment areas do they prefer each product? Understanding their rationale helps assess their depth of knowledge.
Inquire about their approach to dosing and what they would recommend for your specific goals. A provider who cannot explain their reasoning or who offers only one product without justification may lack comprehensive experience. Ask to see before-and-after photos of their actual patients (not manufacturer-provided images) for treatments similar to yours.
Qualified providers welcome informed patients who ask detailed questions. Hesitation to discuss experience or provide treatment documentation is a potential red flag.
Cost Comparison
Comparing costs between Botox and Dysport requires understanding unit-based pricing. If Dysport is priced lower per unit but requires 2.5-3 times more units for equivalent effect, the total treatment cost may be comparable or even higher. Request clear pricing that shows total cost for the planned treatment area rather than per-unit rates alone.
Be cautious of prices significantly below market averages, as this may indicate diluted product, inappropriate dosing, or unqualified providers. Medical tourism involves additional costs—travel, accommodation, potential follow-up visits—that should factor into your overall budget calculation. Our Travel Coordination Services can help you plan logistics for international treatment.
Choosing a Qualified Provider
For international patients, verifying provider credentials and facility standards requires additional diligence. Confirm the provider is licensed to practice in their jurisdiction and has specific training in botulinum toxin administration. Request information about the facility's accreditation and emergency protocols.
Learn more about our Accredited Facilities and their safety standards. You can also browse our Provider Network to find qualified practitioners experienced in botulinum toxin administration.
Verify Product Authenticity
Verify that the product being used is authentic and properly stored. Both products require refrigeration, and you have the right to see the vial before treatment. Suspiciously low prices or reluctance to show product packaging should raise concerns.
Your Treatment Action Plan
Taking a structured approach to your treatment planning supports safer outcomes and better results.
Before Your Consultation
Research providers thoroughly by reviewing credentials, patient testimonials, and before-and-after galleries. Prepare a list of questions covering product experience, pricing structure, emergency protocols, and aftercare support. Document your complete medical history, including medications, supplements, previous reactions, and relevant conditions.
Set realistic expectations based on evidence rather than marketing claims. Understanding that results vary based on individual anatomy, muscle strength, and metabolism helps frame realistic goals.
Post-Treatment Recovery
Plan for appropriate recovery time, particularly if traveling internationally. Most patients can resume normal activities within 24-48 hours, but strenuous exercise, alcohol consumption, and extensive sun exposure should be avoided initially. Flying within a few days of treatment may be advisable to avoid for some patients—discuss travel timing with your provider.
Schedule follow-up assessments appropriately. The full effect of treatment typically develops over 7-14 days, making a two-week post-treatment evaluation useful for assessing results and planning future treatments if needed.
2.Walker TJ, Dayan SH.. “Comparison and Overview of Currently Available Neurotoxins.” Journal of Clinical and Aesthetic Dermatology. 2014. Accessed 2026-02-20.https://pmc.ncbi.nlm.nih.gov/articles/PMC3935649/
